Michael Kelly serves as Vice President, Clinical Development at Hemab. Mike has over 20 years of experience in hematology oncology clinical practice and clinical research. Prior to joining Hemab, Mike served as Vice President, Head of Clinical Development at Syros Pharmaceuticals where he led teams in the design and execution of Phase 1-3 trials in hematologic malignancies and solid tumors. Previously, he was a Clinical Associate Professor of Pediatrics at Tufts University School of Medicine and a practicing pediatric hematology oncologist where he cared for pediatric patients with bleeding disorders and led the oversight and execution of clinical trials. He has authored over 30 research publications. He is Board Certified in Pediatrics and Pediatric Hematology Oncology. He received his MD from Drexel University College of Medcine, Master of Public Health from Brown University, and a Masters in Clinical and Translational Science from Tufts University.